1 / 10

Ethical Relationships Between Doctors, Healthcare Providers, and Pharmaceutical Companies

This paper examines the ethical scrutiny required in the relationships between doctors, hospitals, clinics, and pharmaceutical companies. It highlights the irrational drug prescriptions, potential conflicts of interest, and the importance of maintaining a rational use of drugs. The discussion includes ethical concerns about receiving commissions from pharmaceutical companies, the implications for patient care, and the need for professional integrity. Ethical sponsorships and professional values such as non-maleficence and beneficence are also explored, emphasizing the impact on patient outcomes.

amity-barrera
Télécharger la présentation

Ethical Relationships Between Doctors, Healthcare Providers, and Pharmaceutical Companies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ETHICAL RELATIONSHIP BETWEEN DOCTORS, HEALTH CARE PROVIDER (HOSPITAL, CLINIC) AND PHARMACEUTICAL COMPANY

  2. A4AwaluddinIdrisYogieSetyabudiSyaiful AnwarAriefAbidinM. ZulfikarAzharSteffiziaRodelaBashirahBertilaDustiAltarningtyasAtikaKamiliaNovraRizkiaArifianne

  3. Why the relationship between doctor / hospital / clinic and pharmaceutical industry requires scrutiny from ethical perspective ? • Dalamprakteksehari - hari, ketidakrasionalanpenggunaanobatbanyakdijumpaidanberagamjenisnya, mulaidariperesepanobattanpaindikasi, pemberian yang tidaktepat, peresepanobat yang mahal, ataumanfaatnya yang maishdiragukan, sertapraktekpoilfarmasi. (WHO, 1988; Depkes RI, 1992 ) • Hubungandokter, RS atauklinikdanperusahaanobatbutuhpengawasankarenadalamhubungantersebutharustetapmutualismetapiharustetapmenjagapenggunaanobat yang rasional ( RUD ) sehinggatidakmerugikanpasien

  4. Is it ethical for doctors to receive commission ( in form of cash or facilities from a pharmaceutical company for prescribing certain drugs ? Why ? What would be impact to patients ? • PadapasalKodeEtiktelahdijelaskanbahwamenerimakomisidariperusahaanfarmasisangatbertentangandengankodeetikkedokteran. • Pasal 3 jugadisebutkanbahwadoktertidakbolehdipengaruhiolehsesuatu yang mengakibatkanhilangnyakebebasandankemadirianprofesi. • Contohperbuatan yang bertentangan, misalnya : • Menerimaimbalandariperusahaanfarmasiatauobatataubadan lain yang dapatmemepengaruhipekerjaandokter • Melibatkandirisecaralangsungatautidaklangsunguntukmempromosikanobat, alatataubahan lain untukkeuntunganpribadidokter

  5. Impact to patients • Dokterharusmempertimbangkansegalaaspekdalammemberikanpelayanankesehatan, misalnyapadapasien yang kurangmampudankitamemberikansegalamacamobat yang beberapaobatnyaternyatatidakperludiberikanatauterlalumahalharganya , halinipastiakanmemberatkanpasien. • Sebagaiseorangdokterkitaharusbisamemperhatikanmulaidariaspekekonomi, sosial, budaya, & demografiuntukmemberikansuatutindakan.

  6. Is it possible for a pharmaceutical company to give an ethical sponsorship ? Why / how? PengurusPusat GP Farmasi Indonesia bersamasama denganPengurusBesarIkatanDokter Indonesia dan disaksikanolehPemerintahdenganinimeneguhkan kembalitentangpromosiobat yang beretika : Poinkeenam : Pemberian donasi dan atau hadiah dari perusahaan farmasi hanya diperbolehkan untuk organisasi profesikedokteran dan tidak diberikan kepada dokter secaraindividual.

  7. Professional values that could be violated when a doctor has a financial relationship with a pharmaceutical company or apothecary • Non maleficience Seorangdoktertidakseharusnyamerugikanpasienbaikdalamhalmeresepkanobattanpaindikasi, melebihkandosisdari yang seharusnyadibutuhkan, dandengansengajameresepkanobat non-generikkepadapasientanpapenjelasan yang padaakhirnyaakanmemberikanbebanfinansialkepadapasien.

  8. Professional Values • Beneficience Sudahsemestinyaseorangdokterhanyamemberikanintervensimedis yang salahsatunyaadalahobat-obatan yang memilikidampakmenguntungkanbagipasien

  9. DaftarPustaka • http ://www.dikti.go.id/files/atur/sehat/kode=etik-kedokteran.pdf • http ://www.ranzcp.org/files/ranzcp-attachments/Resources/College_statements/ethical_guidelines.pdf • Best practices : Developing Ethical Guidelines for pharmaceutical company support in an academic mental health center

  10. Alhamdulillah~(^_^~) ~(^_^)~ (~^_^)~

More Related